Treatment results in remission for about 85% of patients with antineutrophil cytoplasmic antibody (ANCA)-associated small-vessel vasculitis; however, 11–57% of these suffer relapse, which can ...

Although immunosuppressive treatment of antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis results in a 10-year survival rate of 60–90%, a substantial number of patients suffer ...

Children with AAV and kidney disease face increased risks for long-term renal damage at 1 year, despite the majority achieving inactive renal disease by this time.

Lesions in ANCA-associated vasculitides are characterized by neutrophil infiltration within the blood-vessel wall. Neutrophils have left the bloodstream and become fully activated in the vascular ...

Well, we are very excited that we have multiple development in the study of treatment of vasculitis, and this is all because ...